Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Topographies of Cortical and Subcortical Volume Loss in HIV and Aging in the cART Era.

Guha A, Brier MR, Ortega M, Westerhaus E, Nelson B, Ances BM.

J Acquir Immune Defic Syndr. 2016 Dec 1;73(4):374-383.

2.

Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era.

Cohen RA, Harezlak J, Schifitto G, Hana G, Clark U, Gongvatana A, Paul R, Taylor M, Thompson P, Alger J, Brown M, Zhong J, Campbell T, Singer E, Daar E, McMahon D, Tso Y, Yiannoutsos CT, Navia B.

J Neurovirol. 2010 Feb;16(1):25-32. doi: 10.3109/13550280903552420.

3.

Regionally Specific Brain Volumetric and Cortical Thickness Changes in HIV-Infected Patients in the HAART Era.

Sanford R, Fernandez Cruz AL, Scott SC, Mayo NE, Fellows LK, Ances BM, Collins DL.

J Acquir Immune Defic Syndr. 2017 Apr 15;74(5):563-570. doi: 10.1097/QAI.0000000000001294.

4.

Clinical factors related to brain structure in HIV: the CHARTER study.

Jernigan TL, Archibald SL, Fennema-Notestine C, Taylor MJ, Theilmann RJ, Julaton MD, Notestine RJ, Wolfson T, Letendre SL, Ellis RJ, Heaton RK, Gamst AC, Franklin DR Jr, Clifford DB, Collier AC, Gelman BB, Marra C, McArthur JC, McCutchan JA, Morgello S, Simpson DM, Grant I; CHARTER Group.

J Neurovirol. 2011 Jun;17(3):248-57. doi: 10.1007/s13365-011-0032-7. Epub 2011 May 5.

5.

Cerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes.

Cohen RA, Harezlak J, Gongvatana A, Buchthal S, Schifitto G, Clark U, Paul R, Taylor M, Thompson P, Tate D, Alger J, Brown M, Zhong J, Campbell T, Singer E, Daar E, McMahon D, Tso Y, Yiannoutsos CT, Navia B; HIV Neuroimaging Consortium.

J Neurovirol. 2010 Nov;16(6):435-44. doi: 10.3109/13550284.2010.520817. Epub 2010 Oct 20.

6.

Regional areas and widths of the midsagittal corpus callosum among HIV-infected patients on stable antiretroviral therapies.

Tate DF, Sampat M, Harezlak J, Fiecas M, Hogan J, Dewey J, McCaffrey D, Branson D, Russell T, Conley J, Taylor M, Schifitto G, Zhong J, Daar ES, Alger J, Brown M, Singer E, Campbell T, McMahon D, Tso Y, Matesan J, Letendre S, Paulose S, Gaugh M, Tripoli C, Yiannoutsos C, Bigler ED, Cohen RA, Guttmann CR, Navia B; HIV Neuroimaging Consortium.

J Neurovirol. 2011 Aug;17(4):368-79. doi: 10.1007/s13365-011-0033-6. Epub 2011 May 10. Erratum in: J Neurovirol. 2011 Aug;17(4):380-1. Schifitto, Giavoni [corrected to Schifitto, Giovanni].

7.

Regional brain structural dysmorphology in human immunodeficiency virus infection: effects of acquired immune deficiency syndrome, alcoholism, and age.

Pfefferbaum A, Rosenbloom MJ, Sassoon SA, Kemper CA, Deresinski S, Rohlfing T, Sullivan EV.

Biol Psychiatry. 2012 Sep 1;72(5):361-70. doi: 10.1016/j.biopsych.2012.02.018. Epub 2012 Mar 27.

8.

Association between brain volumes and HAND in cART-naïve HIV+ individuals from Thailand.

Heaps JM, Sithinamsuwan P, Paul R, Lerdlum S, Pothisri M, Clifford D, Tipsuk S, Catella S, Busovaca E, Fletcher JL, Raudabaugh B, Ratto-Kim S, Valcour V, Ananworanich J; SEARCH 007/011 study groups.

J Neurovirol. 2015 Apr;21(2):105-12. doi: 10.1007/s13365-014-0309-8. Epub 2015 Jan 21.

9.

Neuroimaging markers of human immunodeficiency virus infection in South Africa.

Heaps JM, Joska J, Hoare J, Ortega M, Agrawal A, Seedat S, Ances BM, Stein DJ, Paul R.

J Neurovirol. 2012 Jun;18(3):151-6. doi: 10.1007/s13365-012-0090-5. Epub 2012 Apr 12.

10.

Independent effects of HIV, aging, and HAART on brain volumetric measures.

Ances BM, Ortega M, Vaida F, Heaps J, Paul R.

J Acquir Immune Defic Syndr. 2012 Apr 15;59(5):469-77. doi: 10.1097/QAI.0b013e318249db17.

11.

Micro-structural brain alterations in aviremic HIV+ patients with minor neurocognitive disorders: a multi-contrast study at high field.

Granziera C, Daducci A, Simioni S, Cavassini M, Roche A, Meskaldji D, Kober T, Metral M, Calmy A, Helms G, Hirschel B, Lazeyras F, Meuli R, Krueger G, Du Pasquier RA.

PLoS One. 2013 Sep 10;8(9):e72547. doi: 10.1371/journal.pone.0072547. eCollection 2013.

13.

Brain morphometric correlates of metabolic variables in HIV: the CHARTER study.

Archibald SL, McCutchan JA, Sanders C, Wolfson T, Jernigan TL, Ellis RJ, Ances BM, Collier AC, McArthur JC, Morgello S, Simpson DM, Marra C, Gelman BB, Clifford DB, Grant I, Fennema-Notestine C; CHARTER Group.

J Neurovirol. 2014 Dec;20(6):603-11. doi: 10.1007/s13365-014-0284-0. Epub 2014 Sep 17.

14.

Effects of HIV and combination antiretroviral therapy on cortico-striatal functional connectivity.

Ortega M, Brier MR, Ances BM.

AIDS. 2015 Mar 27;29(6):703-12. doi: 10.1097/QAD.0000000000000611.

15.

Mapping white matter integrity in elderly people with HIV.

Nir TM, Jahanshad N, Busovaca E, Wendelken L, Nicolas K, Thompson PM, Valcour VG.

Hum Brain Mapp. 2014 Mar;35(3):975-92. doi: 10.1002/hbm.22228. Epub 2013 Jan 30.

16.

CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy.

Ellis RJ, Badiee J, Vaida F, Letendre S, Heaton RK, Clifford D, Collier AC, Gelman B, McArthur J, Morgello S, McCutchan JA, Grant I; CHARTER Group.

AIDS. 2011 Sep 10;25(14):1747-51. doi: 10.1097/QAD.0b013e32834a40cd.

17.

Central nervous system penetration effectiveness of antiretroviral drugs and neuropsychological impairment in the Ontario HIV Treatment Network Cohort Study.

Carvalhal A, Gill MJ, Letendre SL, Rachlis A, Bekele T, Raboud J, Burchell A, Rourke SB; Centre for Brain Health in HIV/AIDS.

J Neurovirol. 2016 Jun;22(3):349-57. doi: 10.1007/s13365-015-0404-5. Epub 2015 Nov 16.

PMID:
26572786
18.

HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors.

Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, Corkran SH, Duarte NA, Clifford DB, Woods SP, Collier AC, Marra CM, Morgello S, Mindt MR, Taylor MJ, Marcotte TD, Atkinson JH, Wolfson T, Gelman BB, McArthur JC, Simpson DM, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I; CHARTER Group; HNRC Group.

J Neurovirol. 2011 Feb;17(1):3-16. doi: 10.1007/s13365-010-0006-1. Epub 2010 Dec 21.

19.

Clinical contributors to cerebral white matter integrity in HIV-infected individuals.

Gongvatana A, Cohen RA, Correia S, Devlin KN, Miles J, Kang H, Ombao H, Navia B, Laidlaw DH, Tashima KT.

J Neurovirol. 2011 Oct;17(5):477-86. doi: 10.1007/s13365-011-0055-0. Epub 2011 Oct 1.

20.

Progressive cerebral injury in the setting of chronic HIV infection and antiretroviral therapy.

Gongvatana A, Harezlak J, Buchthal S, Daar E, Schifitto G, Campbell T, Taylor M, Singer E, Algers J, Zhong J, Brown M, McMahon D, So YT, Mi D, Heaton R, Robertson K, Yiannoutsos C, Cohen RA, Navia B; HIV Neuroimaging Consortium.

J Neurovirol. 2013 Jun;19(3):209-18. doi: 10.1007/s13365-013-0162-1. Epub 2013 Apr 24.

Supplemental Content

Support Center